Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| No holders yet. | ||||||||||
AeroVax is McMaster University’s Phase 2 trial of an inhaled, needle-free COVID-19 vaccine (ChAd-triCoV/Mac). Volunteers breathe a two-minute aerosol mist so immunity forms in the lungs, the virus’s entry point.